Skip to content

Local Infiltration With Levobupivacaine During Laparoscopic Cholecystectomy

Laparoscopic Cholecystectomy: Use of Infiltration With Levobupivacaine and Postoperative Pain: A Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04697329
Enrollment
233
Registered
2021-01-06
Start date
2020-12-03
Completion date
2022-05-26
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Cholecystectomy, Levobupivacaine, Local Infiltration, Postoperative Pain

Keywords

Laparoscopic cholecystectomy, Postoperative Pain, Local Infiltration, Levobupivacaine, Randomized controlled trial

Brief summary

Randomized controlled trial on laparoscopic cholecystectomy. Interventional group: preincisional infiltration with levobupivacaine. Control group: no local infiltration. Postoperative pain with numeric rating scale is registered, besides other parameters like heart rate, blood pressure, rescue analgesia requirements, nausea and vomiting, etc.

Interventions

DRUGPreincisional infiltration with levobupivacaine

Local, preincisional infiltration of port sites with levobupivacaine 5 mg/ml 20 ml

Sponsors

Hospital Universitario de Móstoles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective laparoscopic cholecystectomy

Exclusion criteria

* Patient refusal * Open surgery * Reintervention surgery * Drain tube placement * Cognitive impairment * Allergic reactions to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain assessed by visual numeric scale.24 hoursValues come from 0 to 10, where 0 means no pain and 10 means the worst imaginable pain. Best outcome would be 0 or close to 0

Secondary

MeasureTime frameDescription
Postoperative administration of analgesics24 hoursRecord of dose of analgesics needed: nonsteroidal anti-inflamatory drugs, opioid requirements, other analgesics requirements
Postoperative nausea and vomiting episodes24 hoursRecord of episodes of nausea or vomiting during first 24 postoperative hours

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026